PL2719385T3 - Sposób leczenia dysfunkcji termoregulacji za pomocą paroksetyny - Google Patents

Sposób leczenia dysfunkcji termoregulacji za pomocą paroksetyny

Info

Publication number
PL2719385T3
PL2719385T3 PL13190594T PL13190594T PL2719385T3 PL 2719385 T3 PL2719385 T3 PL 2719385T3 PL 13190594 T PL13190594 T PL 13190594T PL 13190594 T PL13190594 T PL 13190594T PL 2719385 T3 PL2719385 T3 PL 2719385T3
Authority
PL
Poland
Prior art keywords
paroxetine
disfunction
treating
treating thermoregulatory
thermoregulatory disfunction
Prior art date
Application number
PL13190594T
Other languages
English (en)
Polish (pl)
Inventor
Patricia Allison Tewes Richards
Original Assignee
Sebela International Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39030027&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL2719385(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sebela International Limited filed Critical Sebela International Limited
Publication of PL2719385T3 publication Critical patent/PL2719385T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • A61K31/36—Compounds containing methylenedioxyphenyl groups, e.g. sesamin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
PL13190594T 2006-08-04 2007-07-31 Sposób leczenia dysfunkcji termoregulacji za pomocą paroksetyny PL2719385T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US11/499,586 US20080033050A1 (en) 2006-08-04 2006-08-04 Method of treating thermoregulatory disfunction with paroxetine
EP13190594.5A EP2719385B1 (en) 2006-08-04 2007-07-31 Method of treating thermoregulatory disfunction with paroxetine
EP07810919.6A EP2068881B1 (en) 2006-08-04 2007-07-31 Method of treating thermoregulatory disfunction with paroxetine
PCT/US2007/017062 WO2008019010A2 (en) 2006-08-04 2007-07-31 Method of treating thermoregulatory disfunction with paroxetine

Publications (1)

Publication Number Publication Date
PL2719385T3 true PL2719385T3 (pl) 2019-06-28

Family

ID=39030027

Family Applications (2)

Application Number Title Priority Date Filing Date
PL13190594T PL2719385T3 (pl) 2006-08-04 2007-07-31 Sposób leczenia dysfunkcji termoregulacji za pomocą paroksetyny
PL07810919T PL2068881T3 (pl) 2006-08-04 2007-07-31 Sposób leczenia dysfunkcji termoregulacji za pomocą paroksetyny

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL07810919T PL2068881T3 (pl) 2006-08-04 2007-07-31 Sposób leczenia dysfunkcji termoregulacji za pomocą paroksetyny

Country Status (27)

Country Link
US (7) US20080033050A1 (enExample)
EP (2) EP2719385B1 (enExample)
JP (2) JP5846717B2 (enExample)
KR (3) KR20140098865A (enExample)
CN (1) CN101505759A (enExample)
AU (1) AU2007282065B2 (enExample)
BR (1) BRPI0715087A2 (enExample)
CA (1) CA2659577C (enExample)
CY (2) CY1120867T1 (enExample)
DK (2) DK2068881T3 (enExample)
ES (2) ES2698207T3 (enExample)
HR (2) HRP20181893T1 (enExample)
HU (2) HUE040099T2 (enExample)
IL (1) IL196844A (enExample)
LT (2) LT2719385T (enExample)
ME (1) ME00592A (enExample)
MX (1) MX2009001275A (enExample)
NO (1) NO343176B1 (enExample)
NZ (1) NZ574735A (enExample)
PL (2) PL2719385T3 (enExample)
PT (2) PT2068881T (enExample)
RS (2) RS57980B1 (enExample)
RU (1) RU2478379C2 (enExample)
SG (1) SG176452A1 (enExample)
SI (2) SI2719385T1 (enExample)
UA (1) UA96770C2 (enExample)
WO (1) WO2008019010A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine
US9211290B2 (en) * 2012-12-31 2015-12-15 Noven Therapeutics, Llc Solid dispersions of amorphous paroxetine mesylate
CA2980990A1 (en) * 2015-04-07 2016-10-13 Meiji Co., Ltd. Hot flash-suppressing agent
KR102817311B1 (ko) 2016-09-29 2025-06-09 (주)아모레퍼시픽 젖산을 유효성분으로 포함하는 열성홍조 개선용 건강식품 조성물

Family Cites Families (52)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1422263A (en) * 1973-01-30 1976-01-21 Ferrosan As 4-phenyl-piperidine compounds
GB8520154D0 (en) * 1985-08-10 1985-09-18 Beecham Group Plc Chemical process
EP0223403B1 (en) * 1985-10-25 1993-08-04 Beecham Group Plc Piperidine derivative, its preparation, and its use as medicament
GB8714707D0 (en) * 1987-06-23 1987-07-29 Beecham Group Plc Chemical process
GB9325644D0 (en) * 1993-12-15 1994-02-16 Smithkline Beecham Plc Novel formulation
US5470846A (en) * 1994-01-14 1995-11-28 Sandyk; Reuven Treatment of neurological and mental disorders
JPH0837567A (ja) 1994-07-26 1996-02-06 Olympus Optical Co Ltd 情報記録媒体及び情報再生装置
US5856493A (en) * 1995-02-06 1999-01-05 Smithkline Beecham Corporation Process for making novel form of paroxeting hydrochloride anhydrate
SE9501567D0 (sv) * 1995-04-27 1995-04-27 Astra Ab A new combination
US6548084B2 (en) * 1995-07-20 2003-04-15 Smithkline Beecham Plc Controlled release compositions
JP3882224B2 (ja) * 1996-05-31 2007-02-14 旭硝子株式会社 パロキセチンの製造方法
US6638948B1 (en) 1996-09-09 2003-10-28 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
US5672612A (en) * 1996-09-09 1997-09-30 Pentech Pharmaceuticals, Inc. Amorphous paroxetine composition
CA2193939C (en) * 1996-12-24 2002-02-12 K.S. Keshava Murthy Useful form of anhydrous paroxetine hydrochloride
GB9700690D0 (en) * 1997-01-15 1997-03-05 Smithkline Beecham Plc Novel process
GB9710004D0 (en) * 1997-05-17 1997-07-09 Knoll Ag Chemical process
NZ501285A (en) * 1997-05-29 2001-10-26 Smithkline Beecham Corp Process for preparing 4-(4'-fluorophenyl)-3-(3', 4'-methylenedioxy-phenyl)-piperidine
US5910319A (en) * 1997-05-29 1999-06-08 Eli Lilly And Company Fluoxetine enteric pellets and methods for their preparation and use
JP2002503248A (ja) * 1997-06-10 2002-01-29 シントン・ベスローテン・フェンノートシャップ ４−フェニルピペリジン化合物
US5955475A (en) * 1997-06-30 1999-09-21 Endo Pharmaceuticals Inc. Process for manufacturing paroxetine solid dispersions
SE9900190D0 (sv) * 1999-01-22 1999-01-22 Astra Ab New compounds
SE9702799D0 (sv) * 1997-07-25 1997-07-25 Astra Ab New compounds
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
IL138084A0 (en) 1998-03-02 2001-10-31 Lilly Co Eli Fluoxetine hydrochloride for decreasing hot flashes
CA2323896A1 (en) * 1998-03-16 1999-09-23 Andrew Simon Craig Crystalline form of paroxetine
US6699882B2 (en) * 1998-03-24 2004-03-02 Smithkline Beecham P.L.C. Paroxetine compositions
US20030028027A1 (en) * 1998-04-09 2003-02-06 Smithkline Beecham Plc Paroxetine maleate
JP3796351B2 (ja) * 1998-04-13 2006-07-12 住友化学株式会社 パロキセチン塩酸塩無水和物の乾燥方法
US6168805B1 (en) 1998-05-07 2001-01-02 Endo Pharmaceuticals, Inc. Aqueous process for manufacturing paroxetine solid dispersions
CH689805A8 (fr) * 1998-07-02 2000-02-29 Smithkline Beecham Plc Méthanesulfonate de paroxétine, procédé pour sa préparation et compositions pharmaceutiques le contenant.
ES2138937B1 (es) * 1998-07-07 2000-10-01 Medichem Sa Polimorfo de maleato de paroxetina y formulaciones farmaceuticas que lo contienen.
ES2159260B1 (es) * 1999-06-22 2002-05-01 Smithkline Beechan Plc Nueva composicion de metanosulfonato de paroxetina
US6369051B1 (en) * 2000-07-06 2002-04-09 American Home Products Corporation Combinations of SSRI and estrogenic agents
US6660298B1 (en) * 2000-07-27 2003-12-09 Pentech Pharmaceuticals, Inc. Paroxetine tablets and capsules
EP1313474A2 (en) 2000-08-28 2003-05-28 Synthon B.V. Paroxetine compositions and processes for making the same
US6498184B2 (en) * 2000-12-05 2002-12-24 Akzo Nobel N.V. Serotonergic compound for a method of treatment of hot flushes in post-menopausal women
JP2004520333A (ja) * 2001-01-04 2004-07-08 フエルレル インターナショナル，ソシエダッド アノニマ （±）−トランス−４−ｐ−フルオロフェニル−３−ヒドロキシメチル−１−メチルピペリジンの製造方法。
DE20100529U1 (de) 2001-01-11 2001-05-10 Synthon Bv Pharmazeutische Tablette umfassend Paroxetinmesylat
NL1017421C2 (nl) * 2001-02-21 2002-01-15 Synthon Bv Werkwijze voor het vervaardigen van paroxetine.
EP1266659A1 (en) 2001-06-11 2002-12-18 Pantarhei Bioscience B.V. Pyridoxal in combination with serotonin re-uptake inhibitor for the treatment of hot flushes
US6956121B2 (en) * 2002-03-01 2005-10-18 Teva Pharmaceutical Industries Ltd. Preparation of paroxetine involving novel intermediates
MXPA05001705A (es) * 2002-08-14 2005-04-19 Pharmacia & Upjohn Co Llc Uso de reboxetina para el tratamiento de sofocos.
US20040152710A1 (en) 2002-10-15 2004-08-05 Deecher Darlene Coleman Use of norepinephrine reuptake modulators for preventing and treating vasomotor symptoms
ITMI20022344A1 (it) * 2002-11-05 2004-05-06 Biofarm Srl Prodotto in pellicola a rapida dissoluzione in acqua, per il trattamento del latte con batteri e/o enzimi.
TWI267838B (en) * 2003-01-03 2006-12-01 Lite On It Corp Method to detect the type of optical disk
US20050130987A1 (en) 2003-10-14 2005-06-16 Wyeth Methods of treating vasomotor symptoms
RU2007102292A (ru) * 2004-07-22 2008-08-27 Вайет (Us) Способ лечения расстройств и заболеваний нервной системы
KR20070034129A (ko) * 2004-07-22 2007-03-27 와이어쓰 신경계 질환 및 장애의 치료 방법
US20060100263A1 (en) * 2004-11-05 2006-05-11 Anthony Basile Antipyretic compositions and methods
KR100764679B1 (ko) 2005-07-22 2007-10-09 익수제약 주식회사 파록세틴을 함유하는 경피투여용 패취제
ATE544444T1 (de) * 2005-10-11 2012-02-15 Yissum Res Dev Co Zusammensetzungen für die nasale abgabe
US20080033050A1 (en) 2006-08-04 2008-02-07 Richards Patricia Allison Tewe Method of treating thermoregulatory disfunction with paroxetine

Also Published As

Publication number Publication date
JP5846717B2 (ja) 2016-01-20
PT2719385T (pt) 2018-12-04
EP2068881A2 (en) 2009-06-17
ES2698207T3 (es) 2019-02-01
SI2719385T1 (sl) 2019-01-31
WO2008019010A2 (en) 2008-02-14
US20140235674A1 (en) 2014-08-21
NZ574735A (en) 2011-03-31
SG176452A1 (en) 2011-12-29
AU2007282065A1 (en) 2008-02-14
DK2068881T3 (en) 2018-12-10
EP2719385B1 (en) 2018-08-29
ES2699298T3 (es) 2019-02-08
US20150335631A1 (en) 2015-11-26
NO343176B1 (no) 2018-11-26
PL2068881T3 (pl) 2019-04-30
US9393237B2 (en) 2016-07-19
US8658663B2 (en) 2014-02-25
JP5895009B2 (ja) 2016-03-30
US20180036299A1 (en) 2018-02-08
CA2659577C (en) 2015-11-24
SI2068881T1 (sl) 2019-01-31
US20200268733A9 (en) 2020-08-27
CN101505759A (zh) 2009-08-12
JP2014077023A (ja) 2014-05-01
EP2068881A4 (en) 2009-09-30
HRP20181925T1 (hr) 2019-01-11
CA2659577A1 (en) 2008-02-14
IL196844A (en) 2015-11-30
NO20090639L (no) 2009-02-25
US8859576B2 (en) 2014-10-14
CY1120867T1 (el) 2019-12-11
HUE040099T2 (hu) 2019-02-28
WO2008019010A3 (en) 2008-12-24
KR20150132888A (ko) 2015-11-26
JP2009545593A (ja) 2009-12-24
US20140249182A1 (en) 2014-09-04
KR20090040453A (ko) 2009-04-24
RU2478379C2 (ru) 2013-04-10
RU2009107739A (ru) 2010-09-10
US8946251B2 (en) 2015-02-03
EP2068881B1 (en) 2018-08-22
HUE040481T2 (hu) 2019-03-28
IL196844A0 (en) 2009-12-24
HRP20181893T1 (hr) 2019-01-11
UA96770C2 (uk) 2011-12-12
AU2007282065B2 (en) 2013-05-09
PT2068881T (pt) 2018-11-29
LT2068881T (lt) 2018-12-10
US20080033050A1 (en) 2008-02-07
DK2719385T3 (en) 2018-12-10
US20090275615A1 (en) 2009-11-05
ME00592B (me) 2011-12-20
US20170165251A1 (en) 2017-06-15
EP2719385A1 (en) 2014-04-16
BRPI0715087A2 (pt) 2015-02-10
KR20140098865A (ko) 2014-08-08
MX2009001275A (es) 2009-04-16
RS57980B1 (sr) 2019-01-31
ME00592A (en) 2011-12-20
LT2719385T (lt) 2018-12-27
RS58046B1 (sr) 2019-02-28
CY1120902T1 (el) 2019-12-11

Similar Documents

Publication Publication Date Title
EP2032131A4 (en) Methods of Treatment
ZA200905236B (en) Knitting loom and method of use
BRPI0910598A2 (pt) refratário contendo zircônia-carbono e método de produção do mesmo
ZA200908708B (en) Heater and method of operation
ATE465229T1 (de) Textilbehandlungsverfahren und zusammensetzung
GB2462704B (en) A single crystal component and a method of heat treating a single crystal component
ZA200901452B (en) Treatment of vertigo with acetyl-L-leucine
HRP20181925T1 (hr) Metoda za liječenje termoregulatorne disfunkcije paroksetinom
GB0605360D0 (en) Method of manufacture
DE602006018715D1 (de) Entzerrerschaltung und Methode
GB0718684D0 (en) Treatment method
GB0610746D0 (en) Method of treatment
EP2132251A4 (en) COMPOSITION AND METHOD
IL202002A0 (en) Method of treating diabetes
ZA200808193B (en) Piperidine derivatives useful for treating osteoarthritis and osteoartrosis
EP2164494A4 (en) Methods of Treatment
GB0601950D0 (en) Compositions and methods of treating diabetes
EP1993564A4 (en) METHOD AND COMPOSITION FOR TREATING ALLERGIC DISEASES
HK1131909A (en) Method of treating thermoregulatory disfunction with paroxetine
ZA201007680B (en) Method of treating metalliferrous materials
PL1842931T3 (pl) Sposób obróbki cieplnej
EP2203432A4 (en) PROCESSING METHOD
EP2097552A4 (en) METHOD OF MANUFACTURING USING THE THERMOFORMING
GB0618227D0 (en) Novel method of treatment
GB0624439D0 (en) Technique for treatment of gall-and kidney-stones